These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 375755)
21. Cholinergic influences in tardive dyskinesia. Tamminga CA; Smith RC; Ericksen SE; Chang S; Davis JM Am J Psychiatry; 1977 Jul; 134(7):769-74. PubMed ID: 869054 [TBL] [Abstract][Full Text] [Related]
22. Lecithin in the treatment of tardive dyskinesia. Branchey MH; Branchey LB; Bark NM; Richardson MA Commun Psychopharmacol; 1979; 3(5):303-7. PubMed ID: 548209 [No Abstract] [Full Text] [Related]
23. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management. Nasrallah HA; Dunner FJ; McCalley-Whitters M; Smith RE J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037 [TBL] [Abstract][Full Text] [Related]
25. The use of cholinergic precursors in neuropsychiatric diseases. Rosenberg GS; Davis KL Am J Clin Nutr; 1982 Oct; 36(4):709-20. PubMed ID: 6214943 [TBL] [Abstract][Full Text] [Related]
26. Choline in tardive dyskinesia and Huntington's disease. Davis KL; Hollister LE; Barchas JD; Berger PA Life Sci; 1976 Nov; 19(10):1507-15. PubMed ID: 136581 [No Abstract] [Full Text] [Related]
28. Choline chloride in the treatment of Huntington's disease and tardive dyskinesia: a preliminary report. Davis KL; Berger PA; Hollister LE; Simonton SC Psychopharmacol Bull; 1977 Jul; 13(3):37-8. PubMed ID: 142261 [No Abstract] [Full Text] [Related]
29. Oral choline in tardive dyskinesia. Ray R; Ramakrishnan N; Rao BS Indian J Med Res; 1982 Oct; 76():628-31. PubMed ID: 7152571 [No Abstract] [Full Text] [Related]
30. Therapeutic strategies against tardive dyskinesia. Two decades of experience. Jeste DV; Wyatt RJ Arch Gen Psychiatry; 1982 Jul; 39(7):803-16. PubMed ID: 6131655 [TBL] [Abstract][Full Text] [Related]
31. Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials. Tammenmaa IA; Sailas E; McGrath JJ; Soares-Weiser K; Wahlbeck K Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1099-107. PubMed ID: 15610922 [TBL] [Abstract][Full Text] [Related]
32. Treatment of tardive dyskinesia with choline and tetrabenazine. Snell AP; Cleary M; Sambrook M Postgrad Med J; 1980 Sep; 56(659):663-4. PubMed ID: 7465478 [TBL] [Abstract][Full Text] [Related]
35. CDP-choline for the treatment of tardive dyskinesia: a small negative series. Gelenberg AJ; Wojcik J; Falk WE; Bellinghausen B; Joseph AB Compr Psychiatry; 1989; 30(1):1-4. PubMed ID: 2647398 [TBL] [Abstract][Full Text] [Related]
36. Neurochemical approaches to the treatment of senile dementia. Growdon JH; Corkin S Proc Annu Meet Am Psychopathol Assoc; 1980; 69():281-96. PubMed ID: 7413654 [No Abstract] [Full Text] [Related]
38. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial. Lee JG; Shin BS; Lee YC; Park SW; Kim YH Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029 [TBL] [Abstract][Full Text] [Related]
39. Pilot study of cyproheptadine (Periactin) in tardive dyskinesia [proceedings]. Gardos G; Cole JO Psychopharmacol Bull; 1978 Apr; 14(2):18-20. PubMed ID: 349599 [No Abstract] [Full Text] [Related]
40. Lack of clinically significant improvement of patients with tardive dyskinesia following phosphatidylcholine therapy. Domino EF; May WW; Demetriou S; Mathews B; Tait S; Kovacic B Biol Psychiatry; 1985 Nov; 20(11):1189-96. PubMed ID: 2864962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]